Xwell (XWEL) Research & Development (2010 - 2023)
Xwell (XWEL) posted Research & Development of $273000.0 for Q3 2023, up 33.82% sequentially from $204000.0 in Q2 2023, and down 63.16% YoY from $741000.0 in Q3 2022.
Xwell (XWEL) Research & Development (2010 - 2023) Analysis & Trends
Xwell has reported Research & Development for 9 years, with the latest figure at $273000.0 in Q3 2023.
- Quarterly Research & Development fell 63.16% year-over-year to $273000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $2.1 million (down 74.83% YoY) and the FY2014 annual result came in at $889000.0, down 41.2% from the prior year.
- Research & Development improved to $273000.0 in Q3 2023 per XWEL's latest filing, from $204000.0 in the prior quarter.
- Over five years, Research & Development peaked at $839000.0 in Q2 2022 and troughed at $204000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 364.00 Mn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 412.00 Mn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 171.28 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 126.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | - |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 210.70 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 252.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 52.99 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | - |
| 10 | Xwell | 7.47 Mn | -9.34 Mn | 2.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 273,000.00 |
| Jun 30, 2023 | 204,000.00 |
| Sep 30, 2022 | 741,000.00 |
| Jun 30, 2022 | 839,000.00 |
| Sep 30, 2017 | 3.90 Mn |
| Jun 30, 2017 | 2.69 Mn |
| Mar 31, 2017 | 2.96 Mn |
| Sep 30, 2016 | 1.55 Mn |
| Jun 30, 2016 | 2.18 Mn |
| Mar 31, 2016 | 1.13 Mn |
| Dec 31, 2014 | 219,000.00 |
| Sep 30, 2014 | 228,000.00 |
| Jun 30, 2014 | 217,000.00 |
| Mar 31, 2014 | 225,000.00 |
| Dec 31, 2013 | 233,000.00 |
| Sep 30, 2013 | 542,000.00 |
| Jun 30, 2013 | 467,000.00 |
| Mar 31, 2013 | 270,000.00 |
| Dec 31, 2012 | -454,000.00 |
| Sep 30, 2012 | 997,000.00 |